Cargando…

Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells

BACKGROUND: The autologous nerve graft, despite its donor site morbidity and unpredictable functional recovery, continues to be the gold standard in peripheral nerve repair. Rodent research studies have shown promising results with cell transplantation of human adipose-derived stem cells (hADSC) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Palombella, Silvia, Guiotto, Martino, Higgins, Gillian C., Applegate, Laurent L., Raffoul, Wassim, Cherubino, Mario, Hart, Andrew, Riehle, Mathis O., di Summa, Pietro G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537973/
https://www.ncbi.nlm.nih.gov/pubmed/33023632
http://dx.doi.org/10.1186/s13287-020-01949-4
_version_ 1783590774145810432
author Palombella, Silvia
Guiotto, Martino
Higgins, Gillian C.
Applegate, Laurent L.
Raffoul, Wassim
Cherubino, Mario
Hart, Andrew
Riehle, Mathis O.
di Summa, Pietro G.
author_facet Palombella, Silvia
Guiotto, Martino
Higgins, Gillian C.
Applegate, Laurent L.
Raffoul, Wassim
Cherubino, Mario
Hart, Andrew
Riehle, Mathis O.
di Summa, Pietro G.
author_sort Palombella, Silvia
collection PubMed
description BACKGROUND: The autologous nerve graft, despite its donor site morbidity and unpredictable functional recovery, continues to be the gold standard in peripheral nerve repair. Rodent research studies have shown promising results with cell transplantation of human adipose-derived stem cells (hADSC) in a bioengineered conduit, as an alternative strategy for nerve regeneration. To achieve meaningful clinical translation, cell therapy must comply with biosafety. Cell extraction and expansion methods that use animal-derived products, including enzymatic adipose tissue dissociation and the use of fetal bovine serum (FBS) as a culture medium supplement, have the potential for transmission of zoonotic infectious and immunogenicity. Human-platelet-lysate (hPL) serum has been used in recent years in human cell expansion, showing reliability in clinical applications. METHODS: We investigated whether hADSC can be routinely isolated and cultured in a completely xenogeneic-free way (using hPL culture medium supplement and avoiding collagenase digestion) without altering their physiology and stem properties. Outcomes in terms of stem marker expression (CD105, CD90, CD73) and the osteocyte/adipocyte differentiation capacity were compared with classical collagenase digestion and FBS-supplemented hADSC expansion. RESULTS: We found no significant differences between the two examined extraction and culture protocols in terms of cluster differentiation (CD) marker expression and stem cell plasticity, while hADSC in hPL showed a significantly higher proliferation rate when compared with the usual FBS-added medium. Considering the important key growth factors (particularly brain-derived growth factor (BDNF)) present in hPL, we investigated a possible neurogenic commitment of hADSC when cultured with hPL. Interestingly, hADSC cultured in hPL showed a statistically higher secretion of neurotrophic factors BDNF, glial cell-derived growth factor (GDNF), and nerve-derived growth factor (NFG) than FBS-cultured cells. When cocultured in the presence of primary neurons, hADSC which had been grown under hPL supplementation, showed significantly enhanced neurotrophic properties. CONCLUSIONS: The hPL-supplement medium could improve cell proliferation and neurotropism while maintaining stable cell properties, showing effectiveness in clinical translation and significant potential in peripheral nerve research.
format Online
Article
Text
id pubmed-7537973
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75379732020-10-07 Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells Palombella, Silvia Guiotto, Martino Higgins, Gillian C. Applegate, Laurent L. Raffoul, Wassim Cherubino, Mario Hart, Andrew Riehle, Mathis O. di Summa, Pietro G. Stem Cell Res Ther Research BACKGROUND: The autologous nerve graft, despite its donor site morbidity and unpredictable functional recovery, continues to be the gold standard in peripheral nerve repair. Rodent research studies have shown promising results with cell transplantation of human adipose-derived stem cells (hADSC) in a bioengineered conduit, as an alternative strategy for nerve regeneration. To achieve meaningful clinical translation, cell therapy must comply with biosafety. Cell extraction and expansion methods that use animal-derived products, including enzymatic adipose tissue dissociation and the use of fetal bovine serum (FBS) as a culture medium supplement, have the potential for transmission of zoonotic infectious and immunogenicity. Human-platelet-lysate (hPL) serum has been used in recent years in human cell expansion, showing reliability in clinical applications. METHODS: We investigated whether hADSC can be routinely isolated and cultured in a completely xenogeneic-free way (using hPL culture medium supplement and avoiding collagenase digestion) without altering their physiology and stem properties. Outcomes in terms of stem marker expression (CD105, CD90, CD73) and the osteocyte/adipocyte differentiation capacity were compared with classical collagenase digestion and FBS-supplemented hADSC expansion. RESULTS: We found no significant differences between the two examined extraction and culture protocols in terms of cluster differentiation (CD) marker expression and stem cell plasticity, while hADSC in hPL showed a significantly higher proliferation rate when compared with the usual FBS-added medium. Considering the important key growth factors (particularly brain-derived growth factor (BDNF)) present in hPL, we investigated a possible neurogenic commitment of hADSC when cultured with hPL. Interestingly, hADSC cultured in hPL showed a statistically higher secretion of neurotrophic factors BDNF, glial cell-derived growth factor (GDNF), and nerve-derived growth factor (NFG) than FBS-cultured cells. When cocultured in the presence of primary neurons, hADSC which had been grown under hPL supplementation, showed significantly enhanced neurotrophic properties. CONCLUSIONS: The hPL-supplement medium could improve cell proliferation and neurotropism while maintaining stable cell properties, showing effectiveness in clinical translation and significant potential in peripheral nerve research. BioMed Central 2020-10-06 /pmc/articles/PMC7537973/ /pubmed/33023632 http://dx.doi.org/10.1186/s13287-020-01949-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Palombella, Silvia
Guiotto, Martino
Higgins, Gillian C.
Applegate, Laurent L.
Raffoul, Wassim
Cherubino, Mario
Hart, Andrew
Riehle, Mathis O.
di Summa, Pietro G.
Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
title Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
title_full Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
title_fullStr Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
title_full_unstemmed Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
title_short Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
title_sort human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537973/
https://www.ncbi.nlm.nih.gov/pubmed/33023632
http://dx.doi.org/10.1186/s13287-020-01949-4
work_keys_str_mv AT palombellasilvia humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT guiottomartino humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT higginsgillianc humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT applegatelaurentl humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT raffoulwassim humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT cherubinomario humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT hartandrew humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT riehlemathiso humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells
AT disummapietrog humanplateletlysateasapotentialclinicaltranslatablesupplementtosupporttheneurotrophicpropertiesofhumanadiposederivedstemcells